<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35185830</PMID><DateRevised><Year>2022</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71 Antagonizes Antiviral Effects of Type III Interferon and Evades the Clearance of Intestinal Intraepithelial Lymphocytes.</ArticleTitle><Pagination><StartPage>806084</StartPage><MedlinePgn>806084</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">806084</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2021.806084</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is the major pathogen causing severe neurological complications and hand, foot, and mouth disease. The intestinal mucosal immune system has a complete immune response and immune regulation mechanism, consisting of densely arranged monolayer intestinal epithelial cells (IECs) and intestinal intraepithelial lymphocytes (iIELs) distributed among the IECs, which constitute the first line of intestinal mucosa against infection of foreign pathogens. As an enterovirus, EV71 is transmitted by the intestinal tract; however, the mechanisms it uses to evade the immunosurveillance of the intestinal mucosal immune system are still incompletely clarified. The present study investigated how EV71 evades from recognizing and eliminating IECs, iIELs, and iNK cells. We found that EV71 infection induced a higher level of type III interferons (IFN-&#x3bb;) than type I interferons (IFN-&#x3b2;) in IECs, and the addition of IFN-&#x3bb; markedly restricted EV71 replication in IECs. These results indicate that IFN-&#x3bb; plays a more important role in anti-EV71 intestinal infection. However, EV71 infection could markedly attenuate the antiviral responses of IFN-&#x3bb;. Mechanistically, 2A protease (2Apro) and 3C protease (3Cpro) of EV71 inhibited the IFN-&#x3bb; production and IFN-&#x3bb; receptor expression and further decreased the response of IECs to IFN-&#x3bb;. In addition, we found that EV71-infected IECs were less susceptible to the lysis of intestinal NK (iNK) cells and CD3<sup>+</sup>iIELs. We revealed that the viral 2Apro and 3Cpro could significantly reduce the expression of the ligands of natural killer group 2D (NKG2D) and promote the expression of PD-L1 on IECs, rendering them to evade the recognition and killing of iNK and CD3<sup>+</sup>iIELs. These results provide novel evasion mechanisms of EV71 from intestinal mucosal innate immunity and may give new insights into antiviral therapy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Dong, Liu, Lu and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Yuanmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Diagnostics, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Cai</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">NK cells</Keyword><Keyword MajorTopicYN="N">NKG2D ligands</Keyword><Keyword MajorTopicYN="N">immune evasion</Keyword><Keyword MajorTopicYN="N">intestinal epithelial cells</Keyword><Keyword MajorTopicYN="N">intestinal intraepithelial lymphocytes</Keyword><Keyword MajorTopicYN="N">intestinal mucosal immunity</Keyword><Keyword MajorTopicYN="N">type III interferon</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35185830</ArticleId><ArticleId IdType="pmc">PMC8848745</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2021.806084</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ank N., West H., Paludan S. R. (2006). IFN-lambda: novel antiviral cytokines. J. Interferon. Cytokine Res. 26 373&#x2013;379. 10.1089/jir.2006.26.373</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2006.26.373</ArticleId><ArticleId IdType="pubmed">16734557</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashiru O., Bennett N. J., Boyle L. H., Thomas M., Trowsdale J., Wills M. R. (2009). NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J. Virol. 83 12345&#x2013;12354. 10.1128/JVI.01175-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01175-09</ArticleId><ArticleId IdType="pmc">PMC2786768</ArticleId><ArticleId IdType="pubmed">19793804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett N. J., Ashiru O., Morgan F. J., Pang Y., Okecha G., Eagle R. A., et al. (2010). Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus. J. Immunol. 185 1093&#x2013;1102. 10.4049/jimmunol.1000789</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1000789</ArticleId><ArticleId IdType="pubmed">20530255</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown H., Esterhazy D. (2021). Intestinal immune compartmentalization: implications of tissue specific determinants in health and disease. Mucosal. Immunol. 14 1259&#x2013;1270. 10.1038/s41385-021-00420-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00420-8</ArticleId><ArticleId IdType="pubmed">34211125</ArticleId></ArticleIdList></Reference><Reference><Citation>Carman P., Ernst P., Rosenthal K., Clark D., Befus A., Bienenstock J. (1986). Intraepithelial leukocytes contain a unique subpopulation of NK-like cytotoxic cells active in the defense of gut epithelium to enteric murine coronavirus. J. Immunol. 136 1548&#x2013;1553.</Citation><ArticleIdList><ArticleId IdType="pubmed">3005395</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerboni C., Neri F., Casartelli N., Zingoni A., Cosman D., Rossi P., et al. (2007). Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J. Gen. Virol. 88 242&#x2013;250. 10.1099/vir.0.82125-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82125-0</ArticleId><ArticleId IdType="pubmed">17170457</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Langereis M. A., Lork M., Nguyen M., Hato S. V., Lanke K., et al. (2014). Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 88 3369&#x2013;3378. 10.1128/JVI.02712-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Fielding C. A., Aicheler R., Stanton R. J., Wang E. C., Han S., Seirafian S., et al. (2014). Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS Pathog. 10:e1004058. 10.1371/journal.ppat.1004058</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004058</ArticleId><ArticleId IdType="pmc">PMC4006889</ArticleId><ArticleId IdType="pubmed">24787765</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayday A., Theodoridis E., Ramsburg E., Shires J. (2001). Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat. Immunol. 2 997&#x2013;1003. 10.1038/ni1101-997</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1101-997</ArticleId><ArticleId IdType="pubmed">11685222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez P. P., Mahlakoiv T., Yang I., Schwierzeck V., Nguyen N., Guendel F., et al. (2015). Interferon-lambda and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat. Immunol. 16 698&#x2013;707. 10.1038/ni.3180</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3180</ArticleId><ArticleId IdType="pmc">PMC4589158</ArticleId><ArticleId IdType="pubmed">26006013</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A., Nemati M., Saha B., Bansode Y. D., Jafarzadeh S. (2021). Protective potentials of type III interferons in COVID-19 patients: lessons from differential properties of type I-and III interferons. Viral. Immunol. 34 307&#x2013;320. 10.1089/vim.2020.0076</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2020.0076</ArticleId><ArticleId IdType="pubmed">33147113</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Zhang R., Wu W., Duan G. (2018). Antiviral and inflammatory cellular signaling associated with enterovirus 71 infection. Viruses 10:155. 10.3390/v10040155</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10040155</ArticleId><ArticleId IdType="pmc">PMC5923449</ArticleId><ArticleId IdType="pubmed">29597291</ArticleId></ArticleIdList></Reference><Reference><Citation>Kansler E. R., Li M. O. (2019). Innate lymphocytes-lineage, localization and timing of differentiation. Cell Mol. Immunol. 16 627&#x2013;633. 10.1038/s41423-019-0211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-019-0211-7</ArticleId><ArticleId IdType="pmc">PMC6804950</ArticleId><ArticleId IdType="pubmed">30804475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear H. M., Schoggins J. W., Diamond M. S. (2019). Shared and distinct functions of type I and Type III Interferons. Immunity 50 907&#x2013;923. 10.1016/j.immuni.2019.03.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.03.025</ArticleId><ArticleId IdType="pmc">PMC6839410</ArticleId><ArticleId IdType="pubmed">30995506</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., et al. (2010). The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 84 8051&#x2013;8061. 10.1128/JVI.02491-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Sun Z., Liu X., Jin Q., He B., Wang J. (2011). Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85 8811&#x2013;8818. 10.1128/JVI.00447-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00447-11</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Liu M., Zuo Z., Liu J., Zhang C. (2017). TLR9 Regulates the NF-&#x3ba;B-NLRP3-IL-1&#x3b2; Pathway Negatively in Salmonella-Induced NKG2D-Mediated Intestinal Inflammation. J. Immunol. 199:ji1601416. 10.4049/jimmunol.1601416</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601416</ArticleId><ArticleId IdType="pubmed">28576980</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Zhang C., Zhou Z., Zhang J., Zhang J., Tian Z. (2012). Small intestinal intraepithelial lymphocytes expressing CD8 and T cell receptor &#x3b3;&#x3b4; are involved in bacterial clearance during Salmonella enterica serovar Typhimurium infection. Infect. Immun. 80 565&#x2013;574. 10.1128/IAI.05078-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.05078-11</ArticleId><ArticleId IdType="pmc">PMC3264294</ArticleId><ArticleId IdType="pubmed">22144492</ArticleId></ArticleIdList></Reference><Reference><Citation>Losurdo G., Piscitelli D., Ierardi E., Di Leo A. (2021). Intraepithelial lymphocytes: bystanders or causative factors in functional gastrointestinal disorders? Cell Mol. Immunol. 18 1620&#x2013;1621. 10.1038/s41423-020-00614-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00614-3</ArticleId><ArticleId IdType="pmc">PMC8245457</ArticleId><ArticleId IdType="pubmed">33479415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M. C., et al. (2012). Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 86 3767&#x2013;3776. 10.1128/JVI.06687-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H., Qiu Y., Yang H. (2021). Intestinal intraepithelial lymphocytes: Maintainers of intestinal immune tolerance and regulators of intestinal immunity. J. Leukoc Biol. 109 339&#x2013;347. 10.1002/JLB.3RU0220-111</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3RU0220-111</ArticleId><ArticleId IdType="pmc">PMC7891415</ArticleId><ArticleId IdType="pubmed">32678936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H., Tao W., Zhu S. (2019). T lymphocytes in the intestinal mucosa: defense and tolerance. Cell Mol. Immunol. 16 216&#x2013;224. 10.1038/s41423-019-0208-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-019-0208-2</ArticleId><ArticleId IdType="pmc">PMC6460495</ArticleId><ArticleId IdType="pubmed">30787416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahlakoiv T., Hernandez P., Gronke K., Diefenbach A., Staeheli P. (2015). Leukocyte-derived IFN-alpha/beta and epithelial IFN-lambda constitute a compartmentalized mucosal defense system that restricts enteric virus infections. PLoS Pathog. 11:e1004782. 10.1371/journal.ppat.1004782</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004782</ArticleId><ArticleId IdType="pmc">PMC4388470</ArticleId><ArticleId IdType="pubmed">25849543</ArticleId></ArticleIdList></Reference><Reference><Citation>Montufar-Solis D., Klein J. R. (2006). An improved method for isolating intraepithelial lymphocytes (IELs) from the murine small intestine with consistently high purity. J. Immunol. Methods. 308 251&#x2013;254. 10.1016/j.jim.2005.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2005.10.008</ArticleId><ArticleId IdType="pubmed">16337223</ArticleId></ArticleIdList></Reference><Reference><Citation>Nice T. J., Baldridge M. T., McCune B. T., Norman J. M., Lazear H. M., Artyomov M., et al. (2014). Interferon- cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347 269&#x2013;273. 10.1126/science.1258100</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258100</ArticleId><ArticleId IdType="pmc">PMC4398891</ArticleId><ArticleId IdType="pubmed">25431489</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivares-Villagomez D., Van Kaer L. (2018). Intestinal intraepithelial lymphocytes: sentinels of the mucosal barrier. Trends Immunol. 39 264&#x2013;275. 10.1016/j.it.2017.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2017.11.003</ArticleId><ArticleId IdType="pmc">PMC8056148</ArticleId><ArticleId IdType="pubmed">29221933</ArticleId></ArticleIdList></Reference><Reference><Citation>Onomoto K., Onoguchi K., Yoneyama M. (2021). Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors. Cell Mol. Immunol. 18 539&#x2013;555. 10.1038/s41423-020-00602-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00602-7</ArticleId><ArticleId IdType="pmc">PMC7812568</ArticleId><ArticleId IdType="pubmed">33462384</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathinayake P. S., Hsu A. C., Wark P. A. (2015). Innate immunity and immune evasion by enterovirus 71. Viruses 7 6613&#x2013;6630. 10.3390/v7122961</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122961</ArticleId><ArticleId IdType="pmc">PMC4690884</ArticleId><ArticleId IdType="pubmed">26694447</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson L. W., Artis D. (2014). Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14 141&#x2013;153. 10.1038/nri3608</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3608</ArticleId><ArticleId IdType="pubmed">24566914</ArticleId></ArticleIdList></Reference><Reference><Citation>Pott J., Stockinger S. (2017). Type I and III interferon in the gut: tight balance between host protection and immunopathology. Front. Immunol. 8:258. 10.3389/fimmu.2017.00258</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00258</ArticleId><ArticleId IdType="pmc">PMC5348535</ArticleId><ArticleId IdType="pubmed">28352268</ArticleId></ArticleIdList></Reference><Reference><Citation>Raftery N., Stevenson N. J. (2017). Advances in antiviral immune defence: revealing the importance of the IFN JAK/STAT pathway. Cell Mol. Life Sci. 74 2525&#x2013;2535. 10.1007/s00018-017-2520-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2520-2</ArticleId><ArticleId IdType="pmc">PMC7079803</ArticleId><ArticleId IdType="pubmed">28432378</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M., Khanbabaei H., Teimoori A. (2019). An update on enterovirus 71 infection and interferon type I response. Rev. Med. Virol. 29:e2016. 10.1002/rmv.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2016</ArticleId><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao F., Yu D., Xia P., Wang S. (2021). Dynamic regulation of innate lymphoid cells in the mucosal immune system. Cell Mol. Immunol. 18 1387&#x2013;1394. 10.1038/s41423-021-00689-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00689-6</ArticleId><ArticleId IdType="pmc">PMC8167116</ArticleId><ArticleId IdType="pubmed">33980994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sips M., Sciaranghella G., Diefenbach T., Dugast A. S., Berger C. T., Liu Q., et al. (2012). Altered distribution of mucosal NK cells during HIV infection. Mucosal. Immunol. 5 30&#x2013;40. 10.1038/mi.2011.40</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2011.40</ArticleId><ArticleId IdType="pmc">PMC3740353</ArticleId><ArticleId IdType="pubmed">21993602</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M. J., McMinn P., Ooi M. H. (2010). Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10 778&#x2013;790. 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M. R., Kaminski J. J., Kurt-Jones E. A., Fitzgerald K. A. (2011). Pattern recognition receptors and the innate immune response to viral infection. Viruses 3 920&#x2013;940. 10.3390/v3060920</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3060920</ArticleId><ArticleId IdType="pmc">PMC3186011</ArticleId><ArticleId IdType="pubmed">21994762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Xi X., Lei X., Zhang X., Cui S., Wang J., et al. (2013). Enterovirus 71 protease 2Apro targets MAVS to inhibit antiviral type I interferon responses. PLoS Pathog. 9:e1003231. 10.1371/journal.ppat.1003231</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedekind A., Fritzsch D., Kroger A. (2020). Add on the next level-the time point of the type I IFN response orchestrates the immune response. Cell Mol. Immunol. 17 791&#x2013;793. 10.1038/s41423-020-0442-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0442-7</ArticleId><ArticleId IdType="pmc">PMC7186764</ArticleId><ArticleId IdType="pubmed">32346100</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells A. I., Coyne C. B. (2018). Type III interferons in antiviral defenses at barrier surfaces. Trends Immunol. 39 848&#x2013;858. 10.1016/j.it.2018.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2018.08.008</ArticleId><ArticleId IdType="pmc">PMC6179363</ArticleId><ArticleId IdType="pubmed">30219309</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C. H., Liang C. T., Jiang S. T., Chen K. H., Yang C. C., Cheng M. L., et al. (2019). A Novel murine model expressing a chimeric mSCARB2/hSCARB2 receptor is highly susceptible to oral infection with clinical isolates of enterovirus 71. J. Virol. 93:19. 10.1128/JVI.00183-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00183-19</ArticleId><ArticleId IdType="pmc">PMC6532076</ArticleId><ArticleId IdType="pubmed">30894476</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Yan H. (2021). Mucosal epithelial cells: the initial sentinels and responders controlling and regulating immune responses to viral infections. Cell Mol. Immunol. 18 1628&#x2013;1630. 10.1038/s41423-021-00650-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00650-7</ArticleId><ArticleId IdType="pmc">PMC8082051</ArticleId><ArticleId IdType="pubmed">33927362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Han C., Li T., Li N., Cao X. (2019). The methyltransferase PRMT6 attenuates antiviral innate immunity by blocking TBK1-IRF3 signaling. Cell Mol. Immunol. 16 800&#x2013;809. 10.1038/s41423-018-0057-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-018-0057-4</ArticleId><ArticleId IdType="pmc">PMC6804946</ArticleId><ArticleId IdType="pubmed">29973649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao F., Fessler M. B. (2020). Running interference on miR-33: a new amplification loop for type I interferon in the host antiviral response. Cell Mol. Immunol. 17 1109&#x2013;1110. 10.1038/s41423-020-0373-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0373-3</ArticleId><ArticleId IdType="pmc">PMC7608119</ArticleId><ArticleId IdType="pubmed">32055004</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Wei H., Rui S., Jian Z., Tian Z., Zhou R., et al. (2007). NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc. Natl. Acad. Sci. USA 104 7512&#x2013;7515. 10.1073/pnas.0700822104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0700822104</ArticleId><ArticleId IdType="pmc">PMC1863471</ArticleId><ArticleId IdType="pubmed">17463084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>